Literature DB >> 24830186

Why psychiatry needs psychedelics and psychedelics need psychiatry.

Ben Sessa.   

Abstract

Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential. Without the validation of the medical profession, the psychedelic drugs, and those who take them off-license, remain archaic sentiments of the past, with the users maligned as recreational drug abusers and subject to continued negative opinion. These two disparate groups--psychiatrists and recreational psychedelic drug users--are united by their shared recognition of the healing potential of these compounds. A resolution of this conflict is essential for the future of psychiatric medicine and psychedelic culture alike. Progression will come from professionals working in the field adapting to fit a conservative paradigm. In this way, they can provide the public with important treatments and also raise the profile of expanded consciousness in mainstream society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24830186     DOI: 10.1080/02791072.2014.877322

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  3 in total

Review 1.  Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.

Authors:  Jacob S Aday; Boris D Heifets; Steven D Pratscher; Ellen Bradley; Raymond Rosen; Joshua D Woolley
Journal:  Psychopharmacology (Berl)       Date:  2022-04-01       Impact factor: 4.530

2.  The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.

Authors:  Tomas Frymann; Sophie Whitney; David B Yaden; Joshua Lipson
Journal:  Front Psychol       Date:  2022-05-23

3.  Psychopharmacological dinner: A metaphoric learning of psychedelics from gustatory revelations of a pillbox.

Authors:  Gurudas Khilnani; Rekha Thaddanee; Ajeet Kumar Khilnani; Rakesh Ranjan Pathak
Journal:  Indian J Psychiatry       Date:  2016 Jan-Mar       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.